Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study

Sherif M Gamal, Nermeen Fouad, Nora Yosry, Wael Badr, Nesreen Sobhy

DOI: 10.46497/ArchRheumatol.2022.8888

Issue: Volume 37 - Issue 2 - June 2022
2057 2181

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252

Issue: Volume 37 - Issue 2 - June 2022
2115 2681

Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic

Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam

DOI: 10.46497/ArchRheumatol.2022.8996

Issue: Volume 37 - Issue 2 - June 2022
2081 2162

Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China

Ke Zhang, Chunmei He, Qiaoting Deng, Wengen Li, Zhixiong Zhong, Jingyuan Hou

DOI: 10.46497/ArchRheumatol.2022.8870

Issue: Volume 37 - Issue 1 - March 2022
1356 2095

Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus

Yunus Durmaz, İlker İlhanlı, Pınar Durmaz

DOI: 10.46497/ArchRheumatol.2022.9002

Issue: Volume 37 - Issue 3 - September 2022
1748 1849

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study

Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee

DOI: 10.46497/ArchRheumatol.2022.9140

Issue: Volume 37 - Issue 3 - September 2022
1585 1248

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi

DOI: 10.46497/ArchRheumatol.2022.9217

Issue: Volume 37 - Issue 3 - September 2022
1589 1325

The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus

Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec

DOI: 10.46497/ArchRheumatol.2022.9255

Issue: Volume 37 - Issue 4 - December 2022
1465 1556

MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis

Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao

DOI: 10.46497/ArchRheumatol.2022.9168

Issue: Volume 37 - Issue 4 - December 2022
1871 1826

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients

Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed

DOI: 10.46497/ArchRheumatol.2022.9307

Issue: Volume 37 - Issue 4 - December 2022
1500 1264

Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus

Yuewu Tang, Yi Luo

DOI: 10.46497/ArchRheumatol.2022.9167

Issue: Volume 37 - Issue 4 - December 2022
1417 1346

Role of low-density lipoprotein receptor rs5925 (1959C>T) gene polymorphism in pathogenesis of dyslipidemia among Egyptian lupus nephritis patients

Yumn A. Alsabbagh, Saher A. Ahmed, Heba E. Salama, Mai A. Abd-Elmawla, Hala L. Elgendy

DOI: 10.46497/ArchRheumatol.2022.9247

Issue: Volume 37 - Issue 4 - December 2022
1454 1185

Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?

Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin

DOI: 10.46497/ArchRheumatol.2022.9366

Issue: Volume 37 - Issue 4 - December 2022
3918 1888

Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis

Eman Baraka, Nashwa Hashaad, Walid Abdelhalim, Gehan Elolemy

DOI: 10.46497/ArchRheumatol.2023.8520

Issue: Volume 38 - Issue 1 - March 2023
1321 1256

Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up

Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine

DOI: 10.46497/ArchRheumatol.2023.9448

Issue: Volume 38 - Issue 1 - March 2023
1282 1247

Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity

Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh

DOI: 10.46497/ArchRheumatol.2023.9549

Issue: Volume 38 - Issue 3 - September 2023
1346 979

Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies

Sherif Gamal, Hanaa Rady, Nesreen Sobhy, Ibrahem Siam, Ahmed Soliman, Fatema Elgengehy

DOI: 10.46497/ArchRheumatol.2023.9860

Issue: Volume 38 - Issue 3 - September 2023
1206 950

The effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on cytokines and their related molecules: An ex vivo study on patients with systemic lupus erythematosus

Atefeh Alaei, Mahmoud Mahmoudi, Maryam Sahebari, Zohreh Vahidi, Nafiseh Tabasi, Maryam Rastin

DOI: 10.46497/ArchRheumatol.2023.9941

Issue: Volume 38 - Issue 4 - December 2023
1185 990

Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis

Maka Gegenava, Zviad Kirtava, William KF Kong, Tea Gegenava

DOI: 10.46497/ArchRheumatol.2024.10131

Issue: Volume 39 - Issue 1 - March 2024
1028 731

Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus

Lingyan He, Mingming Yan, Rui Wen, Jiali Li

DOI: 10.46497/ArchRheumatol.2024.9977

Issue: Volume 39 - Issue 2 - June 2024
755 577